Show filters
Resources type
Filter by Resources type
Pathologies
Filter by Pathologies
Technologies
Filter by Technologies
Instruments
Filter by Instruments
59 result(s) found
Sort by:

May. 17, 2024 May. 20, 2024

Event
Ljubljana, Slovenia

14th International Congress on Autoimmunity 2024, Ljubljana, Slovenia

Sebia booth #15

Learn more

Sebia receives U.S. FDA Clearance for the CAPILLARYS 3 DBS devices

Press Release
Apr. 11, 2024

The next generation instrument for screening hemoglobin disorders in newborns.

Apr. 18, 2024 Apr. 20, 2024

Event
Torino, Italy

European Myeloma Network Meeting – EMN 2024

Sebia booth: #9

Learn more

How External Quality Assessment supports quality improvement in laboratory hemoglobinopathy diagnosis

Webinar
Feb. 19, 2024

Educational Workshop with Dr. Barbara De la Salle

HYDRASYS 2 SCAN FOCUSING: Overview

Video
Feb. 13, 2024

Learn more about the HYDRASYS 2 SCAN FOCUSING for a fast and user-friendly gel electrophoresis processing.

Sebia launches M-inSight®, a test for monitoring multiple myeloma patients

Press Release
Dec. 04, 2023

Corgenix, a Sebia Group company, CAP/CLIA clinical laboratory, positions Sebia to globally commercialize M-inSight®, a novel non-invasive liquid biopsy assay for Minimal Residual Disease (MRD) monitoring in multiple myeloma

Dec. 09, 2023 Nov. 11, 2023

Event
San Diego, CA

ASH 2023

Sebia booth: #2455

Learn more

Improving the diagnosis of AATD with aid of Serum Protein Electrophoresis

Webinar
Aug. 23, 2023

Educational Workshop with Dr. Ilaria Ferrarotti